Skip to main content
Watch Insiders

Corporate insider profile

Jason Haas Insider Trades

Latest reported as Corporate insider of LIGAND PHARMACEUTICALS INC (LGND).

Purchase filings
1
Reported companies
2
Net open-market value
-$3,721,382.55
Latest transaction
Aug 12, 2026

Affiliated corporations

Reported company relationships

LGNDLatest reported

LIGAND PHARMACEUTICALS INC

Corporate insider

ODTXPrior filing

Odyssey Therapeutics, Inc.

Chief Financial Officer

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 12, 2026LIGAND PHARMACEUTICALS INC (LGND)Corporate insiderSale7,138$292.81$2,090,062
Jun 12, 2026LIGAND PHARMACEUTICALS INC (LGND)Corporate insiderSale6,461$255.58$1,651,320
May 8, 2026Odyssey Therapeutics, Inc. (ODTX)Chief Financial OfficerOpen Market Purchase1,000$20.00$20,000